Harrison also worked with the NACC study, which follows participants with mild cognitive impairment, Alzheimer’s disease dementia or related dementia, and normal cognition longitudinally and tracks brain imaging and biomarker data to better understand links between clinical evaluation and brain changes associated with Alzheimer’s disease and related dementia.
REVEAL-SCAN study responsibilities will be covered by Clinical Research Coordinator Grace Stockbower and Research Coordinator Benjamin Bear. NACC study responsibilities will be covered by Research Specialist Jacqueline Lane and new Clinical Research Coordinator Matthew Ferrara.